Add BrightSurf on Google Email

Ochsner Health System


Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: a leap toward personalized medicine

A retrospective cohort study found that PERT significantly reduced the incidence of acute pancreatitis episodes among children with recurrent or chronic pancreatitis. The study also identified genetic markers, such as SPINK1 mutation, that influence treatment outcomes and suggest a tailored approach to patient care.

SourceOchsner Health System·JournalThe American Journal of Gastroenterology·DateMar 27, 2024

Study in JAMA Cardiology finds coating on aspirin does not impact effectiveness or safety for cardiovascular patients

A recent study in JAMA Cardiology analyzed data from 15,000 patients and found that enteric coating on aspirin does not change its effectiveness or safety for secondary prevention of cardiovascular events. The study suggests that patients can choose the aspirin formulation that suits them best.

SourceOchsner Health System·JournalJAMA Cardiology·TypeRandomized controlled/clinical trial·DateNov 6, 2023

Case study: overcoming barriers to venom immunotherapy for fire ant allergy patients

A recent case study highlights the challenges faced by families seeking venom immunotherapy for fire ant allergies, particularly in low-income communities. Despite proven safety and effectiveness of treatment, access remains a significant issue due to transportation barriers, lack of childcare, and work constraints.

SourceOchsner Health System·JournalJournal of Allergy and Clinical Immunology·DateAug 23, 2023

Ochsner participates in new study showing potential benefits of normothermic machine perfusion in liver transplantation

A new study published in Annals of Surgery reveals promising results for normothermic machine perfusion in liver transplantation. The randomized controlled trial found that this technology showed particular promise in marginal donors and those with higher risk factors, demonstrating a lower incidence of dysfunction and cardiovascular s...

SourceOchsner Health System·JournalAnnals of Surgery·TypeRandomized controlled/clinical trial·DateJul 17, 2023

New trials show promising, minimally invasive procedure to treat resistant hypertension

A recent study published in JAMA demonstrates the effectiveness of a minimally invasive procedure called renal denervation (RDN) to treat uncontrolled hypertension. RDN uses ultrasound energy delivered through a small balloon to denervate the renal artery, reducing sympathetic nerve activity and decreasing blood pressure.

SourceOchsner Health System·JournalJournal of the American Medical Association·DateMar 16, 2023

JACC study makes case for expanding coverage for carotid artery stenting

A new study published in the Journal of the American College of Cardiology suggests that carotid artery stenting can be just as effective as surgery in preventing long-term stroke and improving durability. The research recommends expanding insurance coverage for this minimally invasive procedure, which can improve blood flow to the brain.

SourceOchsner Health System·JournalJournal of the American College of Cardiology·DateAug 3, 2022

Ochsner study shows that social circumstances have outsized impact on hypertension control

A large clinical trial conducted at Ochsner Health found that social determinants of health, including financial stress and lack of health literacy, have a significant impact on blood pressure control rates among patients with uncontrolled hypertension. The study suggests that these barriers can eliminate racial disparities in hyperten...

SourceOchsner Health System·JournalMayo Clinic Proceedings·DateJul 20, 2022

Changing guidelines for treating mild chronic hypertension in pregnancy

A new study published in the New England Journal of Medicine found that treating even mild forms of high blood pressure during pregnancy is safe and beneficial for both mother and developing baby. The study's results demonstrated a significant decrease in pregnancy complications, including severe preeclampsia and preterm births.

SourceOchsner Health System·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 28, 2022